Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2007; 13(20): 2833-2840
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2833
Figure 1
Figure 1 Evolution of body weight from initial weight as a function of time during the feeding period and at each time point studied after turpentine oil (TO) injection (arrow) for control (CG; ), protein-restricted (PR; ), glutamine (Gln; ) and protein-powder (PP; ) groups. Values are means ± SD. P < 0.05, between CG and other groups from d-7 until d7.
Figure 2
Figure 2 Morphometrics of jejunal villus height (A), jejunal crypt depths (B), and jejunal lamina propria (C), immediately before turpentine oil (TO) injection and 1, and 3 d after TO. Rats received either control ( ), protein-restricted (PR; ), glutamine (Gln; ), or protein-powder (PP; ) supplemented diets. Values are means ± SD. Means without a common letter (a, b or c) differ. eP < 0.05 vs d 0.
Figure 3
Figure 3 Jejunal (A) and liver (B) glutathione (μmol/g tissue) immediately before turpentine oil (TO) injection and 1, 3 and 7 d after TO. Rats received either control ( ), protein-restricted (PR; ), glutamine (Gln; ), or protein-powder (PP; ). Values are means ± SD. Means without a common letter (a, b or c) differ. eP < 0.05 vs d 0.
Figure 4
Figure 4 Plasma levels (g/L) for alpha-1 acid glycoprotein (A) and alpha-2 macroglobulin (B) immediately before turpentine oil (TO) injection and 1, 3 and 7 d after TO. Rats received either control ( ), protein-restricted (PR; ), glutamine (Gln; ), or protein-powder (PP; ) supplemented diets. Values are means ± SD. Means without a common letter (a, b) differ. cP < 0.05 vs d 0.
Figure 5
Figure 5 Jejunal mRNA level for alpha-1 acid glycoprotein (AGP/GAPDH mRNA ratio) one day after turpentine oil injection. Rats received either control ( ), protein-restricted (PR; ), glutamine (Gln; ), or protein-powder (PP; ) supplemented diets. Values are means ± SD. Means without a common letter (a, b or c) differ. eP < 0.05 vs d 0.